ArticleCancer research2012

Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.

Damian McCartan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.